Under construction – not a live service
Sign in
Taking people in ChinaNo phase

Offspring Born to Mothers With Polycystic Ovary Syndrome in Guangzhou Cohort Study

Key facts

Where
Guangzhou, ChinaSee the site

Where in China

  • Guangzhou Women and Children's Medical Center, ChinaGuangzhou, ChinaContact: Xiu Qiu, PhDTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Trial details

Who runs it
Guangzhou Women and Children's Medical Center
Trial code
NCT03742011
Record updated
26 February 2024
Original description
The Offspring Born to Mothers with Polycystic Ovary Syndrome in Guangzhou Cohort study (PCOS-BIG) was established to investigate the short- and long-term effects of intrauterine exposure to maternal PCOS on the health of offspring in Guangzhou, China. Data are collected regarding maternal PCOS subtypes, nursing, diet and education as well as health outcomes in their later life. Biological samples including blood and tissue samples are also collected from participants.Read full original descriptionShow less

Health of Offspring Born to Mothers With Polycystic Ovary Syndrome in Guangzhou Cohort Study

The Offspring Born to Mothers with Polycystic Ovary Syndrome in Guangzhou Cohort study (PCOS-BIG) was established to investigate the short- and long-term effects of intrauterine exposure to maternal PCOS on the health of offspring in Guangzhou, China. Data are collected regarding maternal PCOS subtypes, nursing, diet and education as well as health outcomes in their later life. Biological samples including blood and tissue samples are also collected from participants.

Inclusion: Offspring born to women diagnosed with PCOS; Offspring born to women with <20 weeks of gestation, intended to eventually deliver in Guangzhou Women and Children's Medical Center; Permanent residents or families intended to remain in Guangzhou for ≥3 years.

Exclusion: None.

ClinicalTrials.gov NCT03742011